ADVANTAGE DIAGNOSTICS CORPORATION ADC MULTIPLE DRUG TEST CARD (4013)

Specialty: Toxicology / TDM


Welcome to the PulseAid listing for the ADVANTAGE DIAGNOSTICS CORPORATION ADC MULTIPLE DRUG TEST CARD medical device. This device is used in the Toxicology / TDM healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the Toxicology / TDM healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Cannabinoids (THC) (K023712 | K023712) CLIA WAIVED
Effective Date: 2004-02-24
Cocaine metabolites (K023712 | K023712) CLIA WAIVED
Effective Date: 2004-02-24
Methamphetamines (K023712 | K023712) CLIA WAIVED
Effective Date: 2004-02-24
Opiates (K023712 | K023712) CLIA WAIVED
Effective Date: 2004-02-24
Phencyclidine (PCP) (K023712 | K023712) CLIA WAIVED
Effective Date: 2004-02-24

Other Toxicology / TDM Devices:

Medical DeviceComplexity
Tianjin New Bay Bioresearch Forsure One Step Dip & Read Drug Screen TestView Complexity
APPLIED BIOTECH SIGNIFY DRUG TRACEView Complexity
VARIAN ONSITE TESTCUP IIView Complexity
Boehringer Mannheim Hitachi 911View Complexity
BOEHRINGER MANNHEIM HITACHI 717View Complexity
BTNX, Inc. Rapid Response Multi-Drug Urine Test Cup (Morphine 300)View Complexity
Applied DNA Technologies Bionexia Single and Multi-Strip DOA Cassette and Dipstick Screen PanelsView Complexity
Roche Diagnostics Hitachi 912View Complexity
Guangzhou Wondfo Biotech One Step Urine Test CassetteView Complexity
FOREFRONT DIAGNOSTICS INSTACHECK MULTI-DRUG SCREEN PANEL THC/COCAINE/PCP/MORPHINE 300/METHAMPHETAMINES/BARBITURATES/BENZODIAZEPINES/METHADONEView Complexity